Early investigations suggest that miRNA-328 directly targets ABCG2. Modulating ABCG2 expression through miRNA-328 in glioblastoma cancer stem cells shows promise as a therapeutic intervention, potentially enhancing the effectiveness of chemotherapy in treating this deadly cancer type [66]. This evidence concerns the gene ABCG2 and cancer.